Prem Kumar, MD | |
200 W Esplanade Ave, Suite 312, Kenner, LA 70065-2489 | |
(504) 712-8872 | |
(504) 712-8879 |
Full Name | Prem Kumar |
---|---|
Gender | Male |
Speciality | Allergy & Immunology |
Location | 200 W Esplanade Ave, Kenner, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811910748 | NPI | - | NPPES |
1181382 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 04124R (Louisiana) | Primary |
207R00000X | Internal Medicine | 04124R (Louisiana) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Prem Kumar, MD 200 W Esplanade Ave, Suite 312, Kenner, LA 70065-2489 Ph: (504) 712-8872 | Prem Kumar, MD 200 W Esplanade Ave, Suite 312, Kenner, LA 70065-2489 Ph: (504) 712-8872 |
News Archive
A lack of appropriate treatment for neuropathic and psychogenic pain may cause patients with musculoskeletal pain to suffer a more chronic pain course, according to the latest results of an ongoing Japanese epidemiological study.
Bacteria found in soil around Tokyo are not indigenous to the area. A study published in the BioMedCentral open access journal Saline Systems reveals a large proportion of salt-loving bacteria in non-saline soil around Tokyo. The researchers suggest that dust storms may have carried the bacteria from their natural habitats in China.
Health Robotics today announced the successful global launch of the Beta Installation kick-off for its 3 latest i.v.SOFT Workflow Engine software automation modules [Assist, Label+ and Profile] in Nice [France], the 2010 venue for the European Association of Hospital Pharmacists. i.v.SOFT helps Pharmacy Technicians, I.V. Room Supervisors, and Pharmacy Directors to compound and manage the safe and efficient manual production of IV Admixtures according to hospital-defined sterile compounding guidelines, and to help bring the pharmacies into compliance with USP 797 regulations in the United States and GMP guidelines elsewhere.
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, has presented preclinical results on its new biotherapy, AMEP™ for advanced and metastatic melanoma at the ESGCT (European Society of Gene and Cell Therapy) in Hannover (November 21 to 25, 2009).
› Verified 9 days ago